Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Brace Versus No Brace for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury

30. november 2012 opdateret af: The London Spine Centre

TLSO Versus No Orthosis for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury: A Multicenter Prospective Randomized Equivalence Trial

Braces have been used o treat stable (not requiring surgery) burst fractures with much success. Recently questions have been raised in regards to the importance of the brace. Some studies have results that suggest a brace is not important in having a good outcome. However, this has never been proven. This study is being conducted to see whether or not wearing a brace is important to having a good outcome.

Studieoversigt

Detaljeret beskrivelse

The purpose of this study is to prospectively compare the outcome between patients randomly assigned to a thoracolumbosacral orthosis (TLSO) treatment group or no orthosis (NO) treatment group, for the management of an acute AO type A3 thoracolumbar fracture.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

97

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Ontario
      • London, Ontario, Canada, N6A 5W9
        • London Spine Centre

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

16 år til 60 år (Barn, Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • AO A3 burst fracture between T10 and L3 with associated kyphotic deformity <35 degrees
  • neurologically intact or isolated nerve root deficit
  • age 16-60 years
  • enrollment within 3 days of injury

Exclusion Criteria:

  • neurological deficit
  • can not comply with brace wearing (pregnancy/body mass index >40)
  • mobilized with or without a brace prior to recruitment
  • suffered a pathologic or open fracture
  • alcohol or drug abusers
  • had previous injury or surgery to the thoracolumbar region
  • unable to complete the questionnaires

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: TLSO
TLSO brace 8-10 weeks
Patients in the TLSO arm will remain on bed rest until fitted with a TLSO. They will wear the TLSO for 8-10 weeks and mobilized in the brace by a physiotherapist.
Andre navne:
  • TLSO Aspen Medical Products, Irvine, CA, USA
Eksperimentel: No Orthosis
Patients in the No Orthosis group will be mobilized immediately as tolerated by a physiotherapist with restrictions to limit bending or rotating through their trunk. They will be encouraged to return to normal activities after 8 weeks.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Roland Morris Disability Questionnaire
Tidsramme: 3 months post fracture
The primary outcome measure is the Roland Morris Disability Questionnaire (RMDQ) administered at 3 months post fracture. The RMDQ evaluates physical disability secondary to low back pain and is validated, simple to administer, sensitive, and reliable. The questionnaire evaluates 24 items to derive a score that varies between zero (no disability) and twenty-four (severe disability). Three months was chosen because it is the time point at which we expect a significant functional recovery and readiness to resume most normal activities.
3 months post fracture

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
SF-36 physical component summary score
Tidsramme: enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2years
enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2years
SF-36 mental component summary score
Tidsramme: enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years
enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years
VAS pain score
Tidsramme: enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months
enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months
Satisfaction with Treatment
Tidsramme: enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months
Overall satisfaction with treatment was assessed on a seven point scale, using the sentence, "All things considered, how satisfied are you with the results of your recent treatment for your spine fracture?" This is a recommended tool for assessing global satisfaction.
enrollment, 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 24 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juni 2005

Primær færdiggørelse (Faktiske)

1. september 2010

Studieafslutning (Faktiske)

1. september 2011

Datoer for studieregistrering

Først indsendt

22. november 2012

Først indsendt, der opfyldte QC-kriterier

30. november 2012

Først opslået (Skøn)

4. december 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

4. december 2012

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. november 2012

Sidst verificeret

1. november 2012

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 11421

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med TLSO

3
Abonner